These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 20452300

  • 21. The impact of pre-endoscopy proton pump inhibitor use on the classification of non-erosive reflux disease and erosive oesophagitis.
    Gaddam S, Wani S, Ahmed H, Maddur P, Hall SB, Gupta N, Puli SR, Higbee A, Rastogi A, Bansal A, Sharma P.
    Aliment Pharmacol Ther; 2010 Nov; 32(10):1266-74. PubMed ID: 20955446
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Prolonged ambulatory pH monitoring in patients with persistent gastroesophageal reflux disease symptoms: testing while on therapy identifies the need for more aggressive anti-reflux therapy.
    Katzka DA, Paoletti V, Leite L, Castell DO.
    Am J Gastroenterol; 1996 Oct; 91(10):2110-3. PubMed ID: 8855731
    [Abstract] [Full Text] [Related]

  • 24. Heartburn severity does not predict disease severity in patients with erosive esophagitis.
    Fennerty MB, Johnson DA.
    MedGenMed; 2006 Apr 06; 8(2):6. PubMed ID: 16926745
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Control of esophageal and intragastric pH with compounded and manufactured omeprazole in patients with reflux esophagitis: a pilot study.
    Moretzsohn LD, Carvalho EB, Franco JD, Soares MP, Brito EM, Belarmino K, Coelho LG.
    Can J Clin Pharmacol; 2009 Apr 06; 16(1):e264-72. PubMed ID: 19383986
    [Abstract] [Full Text] [Related]

  • 28. Reflux monitoring: on or off therapy?
    Vaezi MF.
    Am J Gastroenterol; 2011 Feb 06; 106(2):183-5. PubMed ID: 21301447
    [Abstract] [Full Text] [Related]

  • 29. A balancing view: Impedance-pH testing in gerd-limited role for now, perhaps more helpful in the future.
    Shay S.
    Am J Gastroenterol; 2009 Nov 06; 104(11):2669-70. PubMed ID: 19888232
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. How to differentiate non-erosive reflux disease from functional heartburn.
    Ke MY.
    J Dig Dis; 2012 Dec 06; 13(12):605-8. PubMed ID: 23134478
    [Abstract] [Full Text] [Related]

  • 32. Idiopathic tracheal stenosis: successful outcome with antigastroesophageal reflux disease therapy.
    Terra RM, de Medeiros IL, Minamoto H, Nasi A, Pego-Fernandes PM, Jatene FB.
    Ann Thorac Surg; 2008 Apr 06; 85(4):1438-9. PubMed ID: 18355548
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The relevance of reflux monitoring off therapy.
    Savarino E, Zentilin P, Savarino V.
    Am J Gastroenterol; 2011 Aug 06; 106(8):1558-9; author reply 1559. PubMed ID: 21811280
    [No Abstract] [Full Text] [Related]

  • 35. Incompetent lower esophageal sphincter.
    Belafsky PC.
    Ear Nose Throat J; 2004 May 06; 83(5):318. PubMed ID: 15195875
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Management of heartburn not responding to proton pump inhibitors.
    Fass R, Sifrim D.
    Gut; 2009 Feb 06; 58(2):295-309. PubMed ID: 19136523
    [Abstract] [Full Text] [Related]

  • 40. Symptom association probability and symptom sensitivity index: preferable but still suboptimal predictors of response to high dose omeprazole.
    Taghavi SA, Ghasedi M, Saberi-Firoozi M, Alizadeh-Naeeni M, Bagheri-Lankarani K, Kaviani MJ, Hamidpour L.
    Gut; 2005 Aug 06; 54(8):1067-71. PubMed ID: 15845561
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.